"Solan" Natural Recordings by Native Speakers
sol·an
1. relating to or derived from the genus Lycopersicon, a group of plants that includes tomatoes, peppers, and eggplants.
2. containing solanine, a type of glycoalkaloid found in these plants.
The word "sol" has several meanings depending on the context:<br><br>1. Short form for the sun, especially in astronomical and poetic contexts.<br>2. A title given to the fifth move in the Major and Minor keys of the system: sol<br>3. Sol (music) A perfect fourth on the solfege system (Sol)-focused vocal learning according to shape or arrange intervals to an ease to music theory improvement.
Soothing or comforting, providing a sense of relief or consolation, especially in times of trouble or hardship.
The Solanaceae family is a group of flowering plants, commonly known as the "nightshade" or "potato" family. This family includes many economically and ecologically important plants, such as:<br><br>1. Potatoes (Solanum tuberosum)<br>2. Tomatoes (Solanum lycopersicum)<br>3. Peppers (Capsicum annuum)<br>4. Eggplants (Solanum melongena)<br>5. Tomatillos (Physalis philadelphica)<br>6. Ground cherries (Solanum pseudocapsicum)<br>7. Potatoes (Solanum tuberosum)<br>8. Brugmansia (Brugmansia spp.)<br>9. Datura (Datura spp.)<br>10. Jimsonweed (Datura stramonium)<br><br>Solanaceae plants are characterized by their branched stems, leaves, and showy flowers that are typically funnel-shaped. Many species in this family are poisonous, and some, like the Deadly Nightshade (Atropa belladonna) and Jimsonweed, have been used as poisonous plants for centuries.<br><br>The Solanaceae family also includes many medicinal and ornamental plants. Some species of Solanaceae are used in traditional medicine, while others, like the Petunia, are popular ornamental plants.
Solanezumab is a humanized monoclonal antibody that was being developed by Eli Lilly and Company for the treatment of Alzheimer's disease. It targets amyloid beta, a protein fragment that is associated with the disease. The drug was tested in phase III clinical trials but failed to slow cognitive decline in patients with mild Alzheimer's disease.